financetom
Business
financetom
/
Business
/
IBM's Shift Toward Software to Drive Growth, Oppenheimer Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
IBM's Shift Toward Software to Drive Growth, Oppenheimer Says
Nov 21, 2025 9:16 AM

11:49 AM EST, 11/21/2025 (MT Newswires) -- International Business Machines' ( IBM ) shift toward a software-driven business model is setting the stage for faster revenue and margin growth, Oppenheimer said in a Friday note.

The firm expects IBM's ( IBM ) software revenue to grow about 10% annually over the next two years, led by strength in its automation business and Red Hat growth.

IBM's ( IBM ) consulting business is expected to grow at "low single-digits" and is backed by momentum in application services and artificial intelligence-related opportunities tied to its watsonx platform, Oppenheimer said.

"Investors are too conservative on IBM's ( IBM ) transition" to a software-centric company, with the stock still covered by "multiple legacy IT hardware/services analysts," according to the note.

Oppenheimer initiated coverage of IBM ( IBM ) with an outperform rating and a $360 price target.

Shares of IBM ( IBM ) were up more than 2% in recent trading Friday.

Price: 296.69, Change: +6.29, Percent Change: +2.17

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
SoftBank's Son says artificial super intelligence to exist by 2035
SoftBank's Son says artificial super intelligence to exist by 2035
Nov 3, 2024
TOKYO, Oct 29 (Reuters) - SoftBank Group CEO Masayoshi Son reiterated his belief in the coming of artificial super intelligence (ASI) on Tuesday, saying it would require hundreds of billions of dollars of investment to realise. Artificial super intelligence will be 10,000 times smarter than a human brain and will exist by 2035, Son told an audience of global business,...
Stanley Black & Decker Q3 Earnings: Revenue Misses, Cost Savings Drive Margin Gains, Narrows 2024 EPS Guidance & More
Stanley Black & Decker Q3 Earnings: Revenue Misses, Cost Savings Drive Margin Gains, Narrows 2024 EPS Guidance & More
Nov 3, 2024
Stanley Black & Decker Inc ( SWK ) shares are trading lower after the company reported mixed third-quarter results and narrowed its 2024 guidance. SWK reported a third-quarter sales decline of 5.2% year over year to $3.751 billion, missing the consensus estimate of $3.804 billion. Revenue declined as DEWALT growth was offset by mixed-end market demand; infrastructure divestiture impacted revenue...
Nova Leap Health Expands Into Nova Scotia With $1.4 Million Acquisition of Two Home Care Services Companies
Nova Leap Health Expands Into Nova Scotia With $1.4 Million Acquisition of Two Home Care Services Companies
Nov 3, 2024
09:17 AM EDT, 10/29/2024 (MT Newswires) -- Nova Leap Health ( NVLPF ) , a home health care organization, on Tuesday said it will acquire two affiliated home care services companies in Nova Scotia for $1.4 million. According to Nova Leap, the targets reported combined revenue of $2.6 million and net income of $235,000 for the 2023 fiscal year. The...
Incyte raises 2024 sales forecast for top-selling drug Jakafi
Incyte raises 2024 sales forecast for top-selling drug Jakafi
Nov 3, 2024
Oct 29 (Reuters) - Incyte ( INCY ) beat Wall Street estimates for third-quarter revenue and raised annual sales forecast for its top-selling drug on Tuesday, as uptake among patients remained strong. Jakafi is approved for use in patients with two types of blood cancers called myelofibrosis and polycythemia vera (PV). The treatment is also approved for acute graft-versus-host disease...
Copyright 2023-2026 - www.financetom.com All Rights Reserved